دورية أكاديمية
Dynamics of the Immune Response in Hospitalized SARS-CoV-2-infected Cancer Patients.
| العنوان: | Dynamics of the Immune Response in Hospitalized SARS-CoV-2-infected Cancer Patients. |
|---|---|
| المؤلفون: | Aoki MN; Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba, Brazil., Nardin JM; Erasto Gaertner Hospital, Curitiba, Brazil., Huergo LF; Setor Litoral, Federal University of Paraná (UFPR), Matinhos, Brazil., Blanes L; Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba, Brazil., Morales HMP; Erasto Gaertner Hospital, Curitiba, Brazil., Fornazari B; Erasto Gaertner Hospital, Curitiba, Brazil., Conzentino MS; Setor Litoral, Federal University of Paraná (UFPR), Matinhos, Brazil., Migliorini MEA; Erasto Gaertner Hospital, Curitiba, Brazil., Zanette DL; Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba, Brazil. |
| المصدر: | Cancer investigation [Cancer Invest] 2022 Oct; Vol. 40 (9), pp. 750-759. Date of Electronic Publication: 2022 Aug 21. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 8307154 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4192 (Electronic) Linking ISSN: 07357907 NLM ISO Abbreviation: Cancer Invest Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2015- : Abingdon, Oxford : Taylor & Francis Original Publication: [New York, N.Y. : Marcel Dekker, c1983- |
| مواضيع طبية MeSH: | COVID-19* , Neoplasms*, Antibodies, Viral ; Humans ; Immunity ; SARS-CoV-2 |
| مستخلص: | Seroconversion rates were compared between oncological and nononcological patients infected with SARS-CoV-2 during a 14-day hospitalization time. All COVID-19 non-oncological and solid malignancies patients reached 100% seroconversion at day 14, while less than half of the hematological patients were seroconverted at the same time point. Despite the limited number and variability of the patient's cohort, we conclude that there is a delayed seroconversion in the hematological malignancies group, which may be linked to changes in the hematological parameters, immune suppression and/or oncological treatments that are typically associated with these patients. |
| فهرسة مساهمة: | Keywords: COVID-19; IgG antibodies; cancer; immunity; seroconversion |
| المشرفين على المادة: | 0 (Antibodies, Viral) |
| تواريخ الأحداث: | Date Created: 20220811 Date Completed: 20220923 Latest Revision: 20220923 |
| رمز التحديث: | 20240628 |
| DOI: | 10.1080/07357907.2022.2112693 |
| PMID: | 35950647 |
| قاعدة البيانات: | MEDLINE |
PDF full text from Publisher | تدمد: | 1532-4192 |
|---|---|
| DOI: | 10.1080/07357907.2022.2112693 |